SCHEMBL5230476

SCHEMBL5230476

O=S(=O)(Nc1cc(Cl)cc(Cl)c1)c1cc(Br)c(Cl)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.44
ACLY P53396 2/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 1/20 0.41
RAD51 Q06609 1/20 0.40
PTGES2 Q9H7Z7 1/20 0.40
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FKBP1A P62942 1/20 0.38
CCR4 P51679 1/20 0.37
EGFR P00533 1/20 0.37
WDR5 P61964 3/20 0.36
PGR P06401 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230311 0.87 PLAU (0.43) ACLYTP53MAPTALDH1A1PTGES2
SCHEMBL5229967 0.81 P2RX1 (0.47) FBP1ACLYTP53MAPTRAD51
SCHEMBL5231576 0.80 MAPT (0.49) FBP1TP53MAPTALDH1A1RAD51
SCHEMBL5229199 0.77 MAPT (0.68) TP53MAPTALDH1A1LMNATSHR
SCHEMBL5229776 0.77 MEN1 (0.55) FBP1TP53MAPTTSHR
SCHEMBL4879586 0.77 ALDH1A1 (0.52) FBP1TP53MAPTALDH1A1RAD51
SCHEMBL1510259 0.76 FBP1 (0.48) FBP1ACLYTP53MAPTRAD51
SCHEMBL5233848 0.76 ACLY (0.39) ACLYTP53ALDH1A1FKBP1A
SCHEMBL5230621 0.73 CES1 (0.50) TP53MAPTALDH1A1TSHRPGR
SCHEMBL9997253 0.73 PFKFB3 (0.63) FBP1ACLYTP53MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed